Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review

Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review

Lung cancer is the leading cause of cancer-related death worldwide. Since prognosis of early-stage non-small cell lung cancer (NSCLC) remains dismal for common relapses after curative surgery, considerable efforts are currently focused on bringing immunotherapy into neoadjuvant and adjuvant settings...

Full description

Bibliographic Details
Main Authors: Giuseppe Viscardi, Fabiana Vitiello, Alberto Servetto, Valerio Gristina, Elio Gregory Pizzutilo, Maria Anna Canciello, Paola Maria Medusa, Fabio Salomone, Gaetano Di Guida, Mariano Mollica, Luigi Aronne, Roberto Scaramuzzi, Filomena Napolitano, Ciro Battiloro, Francesca Caputo, Marina Gilli, Giuseppe Totaro, Carlo Curcio, Danilo Rocco, Vincenzo Montesarchio
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
neoadjuvant
adjuvant
immune checkpoint inhibitors
immunotherapy
lung cancer
non-small-cell lung carcinoma (NSCLC)
Online Access:https://www.mdpi.com/2072-6694/14/23/5810

Internet

https://www.mdpi.com/2072-6694/14/23/5810

Similar Items